E. Ferrannini, The theoretical bases of indirect calorimetry: A review, Metabolism, vol.37, issue.3, pp.287-301, 1988.
DOI : 10.1016/0026-0495(88)90110-2

M. Müller, A. Bosy-westphal, D. Kutzner, and M. Heller, Metabolically active components of fat free mass (FFM) and resting energy expenditure (REE) in humans, Forum Nutr, vol.56, pp.301-304, 2003.

M. Taguchi, K. Ishikawa-takata, W. Tatsuta, C. Katsuragi, C. Usui et al., Resting Energy Expenditure Can Be Assessed by Fat-Free Mass in Female Athletes Regardless of Body Size, Journal of Nutritional Science and Vitaminology, vol.57, issue.1, pp.22-31, 2011.
DOI : 10.3177/jnsv.57.22

D. Frankenfield, On heat, respiration, and calorimetry. Nutr Burbank Los Angel Cty Calif, oct, vol.26, issue.10, pp.939-50, 2010.
DOI : 10.1016/j.nut.2010.01.002

V. Weir-de, New methods for calculating metabolic rate with special reference to protein metabolism, The Journal of Physiology, vol.109, issue.1-2, pp.1-9, 1949.
DOI : 10.1113/jphysiol.1949.sp004363

H. Haugen, L. Chan, and F. Li, Indirect Calorimetry: A Practical Guide for Clinicians, Nutrition in Clinical Practice, vol.22, issue.4, pp.377-88, 2007.
DOI : 10.1177/0115426503018005434

C. Compher, D. Frankenfield, N. Keim, and L. Roth-yousey, Best Practice Methods to Apply to Measurement of Resting Metabolic Rate in Adults: A Systematic Review, Journal of the American Dietetic Association, vol.106, issue.6, pp.881-903, 2006.
DOI : 10.1016/j.jada.2006.02.009

H. Haugen, E. Melanson, Z. Tran, J. Kearney, and J. Hill, Variability of measured resting metabolic rate, Am J Clin Nutr. déc, vol.78, issue.6, pp.1141-1146, 2003.

M. Jang, S. Kim, and J. Lee, Cancer cell metabolism: implications for therapeutic targets, Experimental & Molecular Medicine, vol.31, issue.10, p.45, 2013.
DOI : 10.1073/pnas.0914433107

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809361

O. Warburg, F. Wind, E. Negelein, . The, . Of et al., THE METABOLISM OF TUMORS IN THE BODY, The Journal of General Physiology, vol.8, issue.6, pp.519-549, 1927.
DOI : 10.1085/jgp.8.6.519

A. Tijerina, The Biochemical Basis of Metabolism in Cancer Cachexia, Dimensions of Critical Care Nursing, vol.23, issue.6, pp.237-280, 2004.
DOI : 10.1097/00003465-200411000-00001

M. Tisdale, Biology of Cachexia, JNCI Journal of the National Cancer Institute, vol.89, issue.23, pp.1763-73, 1997.
DOI : 10.1093/jnci/89.23.1763

E. Edén, S. Edström, K. Bennegård, T. Scherstén, and K. Lundholm, Glucose flux in relation to energy expenditure in malnourished patients with and without cancer during periods of fasting and feeding, Cancer Res. avr, vol.44, issue.4, pp.1718-1742, 1984.

M. Tisdale, Mechanisms of Cancer Cachexia, Physiological Reviews, vol.89, issue.2, pp.381-410, 2009.
DOI : 10.1152/physrev.00016.2008

C. Holroyde, T. Gabuzda, R. Putnam, P. Paul, and G. Reichard, Altered glucose metabolism in metastatic carcinoma, Cancer Res. déc, vol.35, issue.12, pp.3710-3714, 1975.

M. Tisdale, Metabolic abnormalities in cachexia and anorexia. Nutr Burbank Los Angel Cty Calif, oct, vol.16, issue.10, pp.1013-1017, 2000.

R. Hamanaka and N. Chandel, Targeting glucose metabolism for cancer therapy, The Journal of Cell Biology, vol.196, issue.4, pp.211-216, 2012.
DOI : 10.1084/jem.20120162

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280882

R. Deberardinis, J. Lum, G. Hatzivassiliou, and C. Thompson, The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation, Cell Metabolism, vol.7, issue.1, pp.11-20, 2008.
DOI : 10.1016/j.cmet.2007.10.002

O. Feron, Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells, Radiotherapy and Oncology, vol.92, issue.3, pp.329-362, 2009.
DOI : 10.1016/j.radonc.2009.06.025

J. Razungles, V. Cavaillès, S. Jalaguier, and C. Teyssier, L???effet Warburg, m??decine/sciences, vol.29, issue.11, pp.1026-1059, 2013.
DOI : 10.1051/medsci/20132911020

M. Tisdale, Cachexia in cancer patients, Nature Reviews Cancer, vol.17, issue.11, pp.862-71, 2002.
DOI : 10.1038/nrc927

D. Gould, I. Lahart, A. Carmichael, Y. Koutedakis, and G. Metsios, Cancer cachexia prevention via physical exercise: molecular mechanisms, Journal of Cachexia, Sarcopenia and Muscle, vol.90, issue.1, pp.111-135, 2013.
DOI : 10.1007/s13539-012-0096-0

URL : http://doi.org/10.1007/s13539-012-0096-0

C. Donohoe, A. Ryan, and J. Reynolds, Cancer Cachexia: Mechanisms and Clinical Implications, Gastroenterology Research and Practice, vol.17, issue.10, p.601434, 2011.
DOI : 10.1126/science.1069525

URL : http://doi.org/10.1155/2011/601434

F. Shellock, M. Riedinger, and M. Fishbein, Brown adipose tissue in cancer patients: Possible cause of cancer-induced cachexia, Journal of Cancer Research and Clinical Oncology, vol.184, issue.1, pp.82-87, 1986.
DOI : 10.1007/BF00402783

P. Collins, C. Bing, P. Mcculloch, and G. Williams, Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans, British Journal of Cancer, vol.48, issue.3, pp.372-377, 2002.
DOI : 10.1038/sj.bjc.6600074

J. Gordon, S. Green, and P. Goggin, Cancer cachexia, QJM, vol.98, issue.11, pp.779-88, 2005.
DOI : 10.1093/qjmed/hci127

K. Fearon, D. Hansell, T. Preston, J. Plumb, J. Davies et al., Influence of whole body protein turnover rate on resting energy expenditure in patients with cancer

D. Nixon, M. Kutner, S. Heymsfield, A. Foltz, C. Carty et al., Resting energy expenditure in lung and colon cancer, Metabolism, vol.37, issue.11, pp.1059-64, 1988.
DOI : 10.1016/0026-0495(88)90068-6

S. Thomson, A. Hirshberg, A. Haffejee, and W. Huizinga, Resting metabolic rate of esophageal carcinoma patients: a model for energy expenditure measurement in a homogenous cancer population, Journal of Parenteral and Enteral Nutrition, vol.14, issue.2, pp.119-140, 1990.
DOI : 10.1177/0148607190014002119

A. Jatoi, B. Daly, V. Hughes, G. Dallal, and R. Roubenoff, The prognostic effect of increased resting energy expenditure prior to treatment for lung cancer, Lung Cancer, vol.23, issue.2, pp.153-161, 1999.
DOI : 10.1016/S0169-5002(99)00008-2

M. Reeves, D. Battistutta, S. Capra, J. Bauer, and P. Davies, Resting energy expenditure in patients with solid tumors undergoing anticancer therapy, Nutrition, vol.22, issue.6, pp.609-624, 2006.
DOI : 10.1016/j.nut.2006.03.006

J. Langius, H. Kruizenga, B. Uitdehaag, J. Langendijk, P. Doornaert et al., Resting energy expenditure in head and neck cancer patients before and during radiotherapy, Clinical Nutrition, vol.31, issue.4, pp.549-54, 2012.
DOI : 10.1016/j.clnu.2011.12.009

I. Warnold, K. Lundholm, and T. Scherstén, Energy balance and body composition in cancer patients, Cancer Res. juin, vol.38, issue.6, pp.1801-1808, 1978.

J. Arbeit, D. Lees, R. Corsey, and M. Brennan, Resting Energy Expenditure in Controls and Cancer Patients with Localized and Diffuse Disease, Annals of Surgery, vol.199, issue.3, pp.292-300, 1984.
DOI : 10.1097/00000658-198403000-00008

L. Lindmark, K. Bennegård, E. Edén, L. Ekman, T. Scherstén et al., Resting energy expenditure in malnourished patients with and without cancer, Gastroenterology. août, vol.87, issue.2, pp.402-410, 1984.

A. Hyltander, C. Drott, U. Körner, R. Sandström, and K. Lundholm, Elevated energy expenditure in cancer patients with solid tumours, European Journal of Cancer and Clinical Oncology, vol.27, issue.1, pp.9-15, 1990.
DOI : 10.1016/0277-5379(91)90050-N

W. Chen and Y. Chung, Energy expenditure in patients with hepatocellular carcinoma, Cancer, vol.11, issue.3, pp.590-595, 1994.
DOI : 10.1002/1097-0142(19940201)73:3<590::AID-CNCR2820730315>3.0.CO;2-7

J. Falconer, K. Fearon, C. Plester, J. Ross, and D. Carter, Cytokines, the Acute-Phase Response, and Resting Energy Expenditure in Cachectic Patients with Pancreatic Cancer, Annals of Surgery, vol.219, issue.4, pp.325-356, 1994.
DOI : 10.1097/00000658-199404000-00001

S. Wigmore, J. Falconer, C. Plester, J. Ross, J. Maingay et al., Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients, British Journal of Cancer, vol.72, issue.1, pp.185-193, 1995.
DOI : 10.1038/bjc.1995.300

S. Khor and B. Mohd, Assessing the resting energy expenditure of cancer patients in the Penang General Hospital, Malays J Nutr. avr, vol.17, issue.1, pp.43-53, 2011.

A. Jatoi, B. Daly, V. Hughes, G. Dallal, J. Kehayias et al., Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure?, The Annals of Thoracic Surgery, vol.72, issue.2
DOI : 10.1016/S0003-4975(01)02847-8

D. Cao, G. Wu, B. Zhang, Y. Quan, J. Wei et al., Resting energy expenditure and body composition in patients with newly detected cancer, Clinical Nutrition, vol.29, issue.1, pp.72-79, 2010.
DOI : 10.1016/j.clnu.2009.07.001

A. Roza and H. Shizgal, The Harris Benedict equation reevaluated: resting energy requirements and the body cell mass, Am J Clin Nutr. juill, vol.40, issue.1, pp.168-82, 1984.

B. Harris, A biometric study of basal metabolism in man

W. Boothby and I. Sandiford, Summary of the basal metabolism data on 8,614 subjects with especial reference to the normal standards for the estimation of the basal metabolic rate, J Biol Chem, vol.54, pp.783-803, 1922.

P. García-peris, M. Lozano, C. Velasco, C. De-la-cuerda, T. Iriondo et al., Prospective study of resting energy expenditure changes in head and neck cancer patients treated with chemoradiotherapy measured by indirect calorimetry, Nutrition, vol.21, issue.11-12, pp.11-121107, 2005.
DOI : 10.1016/j.nut.2005.03.006

J. Bauer, M. Reeves, and S. Capra, The agreement between measured and predicted resting energy expenditure in patients with pancreatic cancer ??? A pilot study, Clinical Nutrition, vol.22, issue.1, pp.32-40, 2004.
DOI : 10.1016/S0261-5614(03)80229-7

L. Knox, L. Crosby, I. Feurer, G. Buzby, C. Miller et al., Energy Expenditure in Malnourished Cancer Patients, Annals of Surgery, vol.197, issue.2, pp.152-62, 1983.
DOI : 10.1097/00000658-198302000-00006

A. Jouinot, Resting energy expenditure (REE) for the risk assessment of anticancer treatments: A prospective study in 277 cancer patients. Poster présenté à, 2015.

J. Lieffers, M. Mourtzakis, K. Hall, L. Mccargar, C. Prado et al., A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands, American Journal of Clinical Nutrition, vol.89, issue.4, pp.1173-1182, 2009.
DOI : 10.3945/ajcn.2008.27273

M. Müller, A. Bosy-westphal, D. Kutzner, and M. Heller, Metabolically active components of fat-free mass and resting energy expenditure in humans: recent lessons from imaging technologies, Obesity Reviews, vol.24, issue.2, pp.113-135, 2002.
DOI : 10.1007/s002610000126

A. Sparti, J. Delany, J. De-la-bretonne, G. Sander, and G. Bray, Relationship between resting metabolic rate and the composition of the fat-free mass, Metabolism, vol.46, issue.10, pp.1225-1255, 1997.
DOI : 10.1016/S0026-0495(97)90222-5

T. Agustsson, P. Wikrantz, M. Rydén, T. Brismar, and B. Isaksson, Adipose tissue volume is decreased in recently diagnosed cancer patients with cachexia, Nutrition, vol.28, issue.9, pp.851-856, 2012.
DOI : 10.1016/j.nut.2011.11.026

J. Macfie, L. Burkinshaw, C. Oxby, J. Holmfield, and G. Hill, The effect of gastrointestinal malignancy on resting metabolic expenditure, British Journal of Surgery, vol.1, issue.8, pp.443-449, 1982.
DOI : 10.1002/bjs.1800690803

D. Hansell, J. Davies, and H. Burns, The Relationship Between Resting Energy Expenditure and Weight Loss in Benign and Malignant Disease, Annals of Surgery, vol.203, issue.3, pp.240-245, 1986.
DOI : 10.1097/00000658-198603000-00003

E. Fredrix, P. Soeters, E. Wouters, I. Deerenberg, V. Meyenfeldt et al., Effect of different tumor types on resting energy expenditure, Cancer Res. 15 nov, vol.51, issue.22, pp.6138-6179, 1991.

S. Jebb, R. Osborne, A. Dixon, N. Bleehen, and E. M. , Measurements of resting energy expenditure and body composition before and after treatment of small cell lung cancer, Annals of Oncology, vol.5, issue.10, pp.915-924, 1994.
DOI : 10.1093/oxfordjournals.annonc.a058730

P. Ravasco, I. Monteiro-grillo, and M. Camilo, How Relevant Are Cytokines in Colorectal Cancer Wasting?, The Cancer Journal, vol.13, issue.6, pp.392-400, 2007.
DOI : 10.1097/PPO.0b013e3181594940

P. Ravasco, I. Monteiro-grillo, and M. Camilo, Colorectal Cancer: Intrinsic Characteristics Modulate Cancer Energy Expenditure and the Risk of Cachexia, Cancer Investigation, vol.23, issue.4, pp.308-322, 2007.
DOI : 10.1111/j.1365-2273.1983.tb01429.x

D. Hansell, J. Davies, and H. Burns, The effects on resting energy expenditure of different tumor types, Cancer, vol.230, issue.8, pp.1739-1783, 1986.
DOI : 10.1002/1097-0142(19861015)58:8<1739::AID-CNCR2820580826>3.0.CO;2-X

D. Dempsey, I. Feurer, L. Knox, L. Crosby, G. Buzby et al., Energy expenditure in malnourished gastrointestinal cancer patients. Cancer. 15 mars, pp.1265-73, 1984.

H. Silver, M. Dietrich, and B. Murphy, Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy, Head & Neck, vol.47, issue.10, pp.893-900, 2007.
DOI : 10.1002/hed.20607

K. Norman, C. Pichard, H. Lochs, and M. Pirlich, Prognostic impact of disease-related malnutrition, Clinical Nutrition, vol.27, issue.1, pp.5-15, 2008.
DOI : 10.1016/j.clnu.2007.10.007

R. Maréchal, A. Demols, F. Gay, D. Maertelaere, V. Arvanitaki et al., Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer, Oncology, vol.73, issue.12, pp.41-51, 2007.

J. Bachmann, M. Heiligensetzer, H. Krakowski-roosen, M. Büchler, H. Friess et al., Cachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer, Journal of Gastrointestinal Surgery, vol.45, issue.7, pp.1193-201, 2008.
DOI : 10.1007/s11605-008-0505-z

P. Ross, S. Ashley, A. Norton, K. Priest, J. Waters et al., Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?, British Journal of Cancer, vol.63, issue.10, 2004.
DOI : 10.1038/sj.bjc.6601781

A. Viganó, E. Bruera, G. Jhangri, S. Newman, A. Fields et al., Clinical Survival Predictors in Patients With Advanced Cancer, Archives of Internal Medicine, vol.160, issue.6, pp.861-869, 2000.
DOI : 10.1001/archinte.160.6.861

M. Barret, D. Malka, T. Aparicio, C. Dalban, C. Locher et al., Nutritional Status Affects Treatment Tolerability and Survival in Metastatic Colorectal Cancer Patients: Results of an AGEO Prospective Multicenter Study, Oncology, vol.81, issue.5-6, pp.5-6395, 2011.
DOI : 10.1159/000335478

W. Dewys, C. Begg, P. Lavin, P. Band, J. Bennett et al., Prognostic effect of weight loss prior tochemotherapy in cancer patients, The American Journal of Medicine, vol.69, issue.4, pp.491-498, 1980.
DOI : 10.1016/S0149-2918(05)80001-3

H. Andreyev, A. Norman, J. Oates, and D. Cunningham, Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?, European Journal of Cancer, vol.34, issue.4, pp.503-512, 1990.
DOI : 10.1016/S0959-8049(97)10090-9

M. Pressoir, S. Desné, D. Berchery, G. Rossignol, B. Poiree et al., Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres, British Journal of Cancer, vol.54, issue.6
DOI : 10.1158/1055-9965.EPI-09-0372

A. Fruchtenicht, A. Poziomyck, G. Kabke, S. Loss, J. Antoniazzi et al., Nutritional risk assessment in critically ill cancer patients: systematic review. Rev Bras Ter Intensiva, sept, vol.27, issue.3, pp.274-83, 2015.

S. Liu, W. Tsai, Y. Wong, J. Lin, C. Poon et al., Nutritional factors and survival of patients with oral cancer, Head & Neck, vol.34, issue.11, pp.998-1007, 2006.
DOI : 10.1002/hed.20461

P. Seve, I. Ray-coquard, V. Trillet-lenoir, M. Sawyer, J. Hanson et al., Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site, Cancer, vol.39, issue.11, pp.2698-705, 2006.
DOI : 10.1002/cncr.22300

U. Tirelli, Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience, British Journal of Cancer, vol.99, issue.8, pp.1364-1365, 2008.
DOI : 10.1038/sj.bjc.6604218

C. Deans and S. Wigmore, Systemic inflammation, cachexia and prognosis in patients with cancer, Current Opinion in Clinical Nutrition and Metabolic Care, vol.8, issue.3, pp.265-274, 2005.
DOI : 10.1097/01.mco.0000165004.93707.88

S. Hong, Y. Kang, B. Cho, and D. Kim, Elevated Serum C-Reactive Protein as a Prognostic Marker in Small Cell Lung Cancer, Yonsei Medical Journal, vol.53, issue.1, pp.111-118, 2012.
DOI : 10.3349/ymj.2012.53.1.111

K. Fearon, F. Strasser, S. Anker, I. Bosaeus, E. Bruera et al., Definition and classification of cancer cachexia: an international consensus, The Lancet Oncology, vol.12, issue.5, pp.489-95, 2011.
DOI : 10.1016/S1470-2045(10)70218-7

F. Mahmoud and N. Rivera, The role of C-reactive protein as a prognostic indicator in advanced cancer, Current Oncology Reports, vol.59, issue.3, pp.250-255, 2002.
DOI : 10.1007/s11912-002-0023-1

K. Slaviero, J. Read, S. Clarke, and L. Rivory, Baseline Nutritional Assessment in Advanced Cancer Patients Receiving Palliative Chemotherapy, Nutrition and Cancer, vol.46, issue.2, pp.148-57, 2003.
DOI : 10.1207/S15327914NC4602_07

C. Richards, C. Roxburgh, M. Macmillan, S. Isswiasi, E. Robertson et al., The Relationships between Body Composition and the Systemic Inflammatory Response in Patients with Primary Operable Colorectal Cancer, PLoS ONE, vol.7, issue.8, p.41883, 2012.
DOI : 10.1371/journal.pone.0041883.t005

I. Gockel, K. Dirksen, C. Messow, and T. Junginger, Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus, World Journal of Gastroenterology, vol.12, issue.23, pp.3746-50, 2006.
DOI : 10.3748/wjg.v12.i23.3746

K. Hashimoto, Y. Ikeda, D. Korenaga, K. Tanoue, M. Hamatake et al., The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma, Cancer, vol.37, issue.9, pp.1856-64, 2005.
DOI : 10.1002/cncr.20976

M. Hara, Y. Matsuzaki, T. Shimuzu, M. Tomita, T. Ayabe et al., Preoperative serum C-reactive protein level in non-small cell lung cancer, Anticancer Res. août, vol.27, issue.4C, pp.3001-3005, 2007.

P. Karakiewicz, G. Hutterer, Q. Trinh, C. Jeldres, P. Perrotte et al., C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality, Cancer, vol.54, issue.6, pp.1241-1248, 2007.
DOI : 10.1002/cncr.22896

L. Hefler, N. Concin, G. Hofstetter, C. Marth, A. Mustea et al., Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer, Clinical Cancer Research, vol.14, issue.3, pp.710-714, 2008.
DOI : 10.1158/1078-0432.CCR-07-1044

A. Koch, H. Fohlin, and S. Sörenson, Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy, Journal of Thoracic Oncology, vol.4, issue.3, pp.326-358, 2009.
DOI : 10.1097/JTO.0b013e31819578c8

S. Wilop, M. Crysandt, M. Bendel, A. Mahnken, R. Osieka et al., Correlation of C-Reactive Protein with Survival and Radiographic Response to First-Line Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer, Oncology Research and Treatment, vol.31, issue.12, pp.665-70, 2008.
DOI : 10.1159/000165054

F. Bozzetti, . Scrinio-working, and . Group, Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients, Supportive Care in Cancer, vol.32, issue.11)(Suppl, pp.279-84, 2009.
DOI : 10.1007/s00520-008-0476-3

A. Nourissat, D. Mille, G. Delaroche, J. Jacquin, J. Vergnon et al., Estimation of the risk for nutritional state degradation in patients with cancer: development of a screening tool based on results from a cross-sectional survey, Annals of Oncology, vol.18, issue.11, pp.1882-1888, 2007.
DOI : 10.1093/annonc/mdm355

H. Kruizenga, N. Wierdsma, M. A. Van-bokhorst, . De-van-der-schueren-null, H. Haollander et al., Screening of nutritional status in The Netherlands, Clinical Nutrition, vol.22, issue.2, pp.147-52, 2003.
DOI : 10.1054/clnu.2002.0611

W. Evans, J. Morley, J. Argilés, C. Bales, V. Baracos et al., Cachexia: A new definition, Clinical Nutrition, vol.27, issue.6, pp.793-802, 2008.
DOI : 10.1016/j.clnu.2008.06.013

E. Van-cutsem and J. Arends, The causes and consequences of cancer-associated malnutrition, European Journal of Oncology Nursing, vol.9
DOI : 10.1016/j.ejon.2005.09.007

M. Tisdale, Pathogenesis of cancer cachexia, J Support Oncol. oct, vol.1, issue.3, pp.159-68, 2003.

J. Argilés, R. Moore-carrasco, G. Fuster, S. Busquets, and F. López-soriano, Cancer cachexia: the molecular mechanisms, The International Journal of Biochemistry & Cell Biology, vol.35, issue.4, pp.405-414, 2003.
DOI : 10.1016/S1357-2725(02)00251-0

P. Ravasco, I. Monteiro-grillo, P. Vidal, and M. Camilo, Cancer: disease and nutrition are key determinants of patients' quality of life, Support Care Cancer Off J Multinatl Assoc Support Care Cancer. avr, vol.12, issue.4, pp.246-52, 2004.

K. Harvey, A. Bothe, and G. Blackburn, Nutritional assessment and patient outcome during oncological therapy, Cancer, vol.39, issue.S5, pp.2065-2074, 1979.
DOI : 10.1002/1097-0142(197905)43:5+<2065::AID-CNCR2820430714>3.0.CO;2-1

P. Reeds, C. Fjeld, and F. Jahoor, Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states?, J Nutr. juin, vol.124, issue.6, pp.906-916, 1994.

D. Fabbro, E. Hui, D. Dalal, S. Dev, R. Nooruddin et al., Clinical Outcomes and Contributors to Weight Loss in a Cancer Cachexia Clinic, Journal of Palliative Medicine, vol.14, issue.9, pp.1004-1012, 2011.
DOI : 10.1089/jpm.2011.0098

A. Kee, E. Isenring, I. Hickman, and A. Vivanti, Resting energy expenditure of morbidly obese patients using indirect calorimetry: a systematic review, Obesity Reviews, vol.11, issue.9, pp.753-65, 2012.
DOI : 10.1111/j.1467-789X.2012.01000.x

I. Bosaeus, P. Daneryd, E. Svanberg, and K. Lundholm, Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients, International Journal of Cancer, vol.50, issue.3, pp.380-383, 2001.
DOI : 10.1002/ijc.1332

F. Bozzetti, A. Pagnoni, D. Vecchio, and M. , Excessive caloric expenditure as a cause of malnutrition in patients with cancer, Surg Gynecol Obstet. févr, vol.150, issue.2, pp.229-263, 1980.

E. Fredrix, E. Wouters, P. Soeters, A. Van-der-aalst, A. Kester et al., Resting energy expenditure in patients with non-small cell lung cancer, Cancer, vol.82, issue.7, pp.1616-1637, 1991.
DOI : 10.1002/1097-0142(19911001)68:7<1616::AID-CNCR2820680725>3.0.CO;2-3

J. Wu, C. Huang, H. Xiao, Q. Tang, and W. Cai, Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer, Nutrition, vol.29, issue.11-12, pp.11-121310, 2013.
DOI : 10.1016/j.nut.2013.04.010

G. Johnson, A. Sallé, G. Lorimier, L. Laccourreye, B. Enon et al., Cancer cachexia: Measured and predicted resting energy expenditures for nutritional needs evaluation, Nutrition, vol.24, issue.5, pp.443-50, 2008.
DOI : 10.1016/j.nut.2008.01.013

R. Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2014.

M. Harvie, A. Howell, N. Thatcher, A. Baildam, and I. Campbell, Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy ??? a longitudinal study, British Journal of Cancer, vol.6, issue.4, pp.673-80, 2005.
DOI : 10.1046/j.1365-2168.1997.02525.x

J. Harris and F. Benedict, A Biometric Study of Human Basal Metabolism, Proceedings of the National Academy of Sciences, vol.4, issue.12, pp.370-373, 1918.
DOI : 10.1073/pnas.4.12.370

S. Kim, G. Wie, W. Lee, S. Park, and S. Woo, Changes in Dietary Intake, Body Weight, Nutritional Status, and Metabolic Rate in a Pancreatic Cancer Patient, Clinical Nutrition Research, vol.2, issue.2, pp.154-162, 2013.
DOI : 10.7762/cnr.2013.2.2.154

J. Simons, A. Schols, W. Buurman, and E. Wouters, Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones, Clinical Science, vol.97, issue.2, pp.215-238, 1979.
DOI : 10.1042/cs0970215

A. Moses, C. Slater, T. Preston, M. Barber, and K. Fearon, Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids, British Journal of Cancer, vol.90, issue.5
DOI : 10.1038/sj.bjc.6601620

A. Macciò, C. Madeddu, G. Gramignano, C. Mulas, C. Floris et al., A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life, Gynecologic Oncology, vol.124, issue.3
DOI : 10.1016/j.ygyno.2011.12.435

I. Bosaeus, P. Daneryd, and K. Lundholm, Dietary intake, resting energy expenditure, weight loss and survival in cancer patients, J Nutr. nov, vol.132, pp.3465-3466, 2002.

I. Bosaeus, Nutritional support in multimodal therapy for cancer cachexia, Supportive Care in Cancer, vol.30, issue.9, pp.447-51, 2008.
DOI : 10.1007/s00520-007-0388-7

C. Avesani, M. Kamimura, and L. Cuppari, Energy Expenditure in Chronic Kidney Disease Patients, Journal of Renal Nutrition, vol.21, issue.1, pp.27-30, 2011.
DOI : 10.1053/j.jrn.2010.10.013

L. Plank and G. Hill, Sequential Metabolic Changes following Induction of Systemic Inflammatory Response in Patients with Severe Sepsis or Major Blunt Trauma, World Journal of Surgery, vol.24, issue.6, pp.630-638, 2000.
DOI : 10.1007/s002689910104

D. Nieman, M. Austin, L. Benezra, S. Pearce, T. Mcinnis et al., Validation of Cosmed???s FitMate??? in Measuring Oxygen Consumption and Estimating Resting Metabolic Rate, Research in Sports Medicine: An International Journal, vol.14, issue.2
DOI : 10.1080/15438620600651512

K. Gomes-de-lima and R. Maio, Nutritional status, systemic inflammation and prognosis of patients with gastrointestinal cancer, Nutr Hosp. juin, vol.27, issue.3, pp.707-721, 2012.

S. Beck, K. Smith, and M. Tisdale, Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover, Cancer Res. 15 nov, vol.51, issue.22, pp.6089-93, 1991.

S. Wigmore, J. Ross, J. Falconer, C. Plester, M. Tisdale et al., The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer, Nutrition, vol.12
DOI : 10.1016/0899-9007(96)90014-3

M. Barber, D. Mcmillan, T. Preston, J. Ross, and K. Fearon, Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement, Clinical Science, vol.98, issue.4, pp.389-99, 1979.
DOI : 10.1042/cs0980389

J. Simons, A. Schols, J. Hoefnagels, K. Westerterp, G. Velde et al., Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer, Cancer, vol.15, issue.3, pp.553-60, 1998.
DOI : 10.1002/(SICI)1097-0142(19980201)82:3<553::AID-CNCR18>3.0.CO;2-0

Z. Khan, E. Simpson, A. Cole, M. Holt, I. Macdonald et al., Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass, Alimentary Pharmacology and Therapeutics, vol.125, issue.5, pp.677-82, 2003.
DOI : 10.1023/A:1008329821941

J. Gordon, T. Trebble, R. Ellis, H. Duncan, T. Johns et al., Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial, Gut, vol.54, issue.4, pp.540-545, 2005.
DOI : 10.1136/gut.2004.047563

C. Drott, H. Persson, and K. Lundholm, Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer, Clinical Physiology, vol.252, issue.5, pp.427-466, 1989.
DOI : 10.1136/hrt.36.7.719

A. Hyltander, P. Daneryd, R. Sandström, U. Körner, and K. Lundholm, ??-Adrenoceptor activity and resting energy metabolism in weight losing cancer patients, European Journal of Cancer, vol.36, issue.3, pp.330-334, 1990.
DOI : 10.1016/S0959-8049(99)00273-7

A. Gambardella, R. Tortoriello, L. Pesce, M. Tagliamonte, G. Paolisso et al., Intralipid infusion combined with propranolol administration has favorable metabolic effects in elderly malnourished cancer patients, Metabolism, vol.48, issue.3, pp.291-298, 1999.
DOI : 10.1016/S0026-0495(99)90074-4

. Résumé and . Contexte, En oncologie, la cachexie reste une cause importante de mortalité pour laquelle les ressources thérapeutiques sont limitées et le rôle de la dépense énergétique de repos (DER) mal défini. L'objectif de cette étude est d'étudier le lien entre la DER et les marqueurs clinico-biologiques de cachexie en oncologie. Patients et méthodes. Nous avons mesuré la DER par calorimétrie indirecte chez des patients atteints de cancer. Nous avons défini selon l'équation de Harris et Benedict des patients hypermétaboliques (Hm) (DER mesurée >110% de la calculée, normométaboliques (Nm) (90%-110%) et hypométaboliques (Hom) (<90%). Nous avons étudié la perte de poids, le performance status (PS), l'albuminémie, le Nutritional Risk Index (NRI), les apports caloriques journaliers et calculé la balance énergétique

. Résultats, Les Hm étaient plus dénutris que les Nm: perte de poids était de 5,9% vs 3,94 % (p=0,02) et la perte de poids > 5% de 67% vs 50% OR=4 p=0,014. L'albuminémie était plus basse : 39,01 g

. L. Conclusion, hypermétabolisme induit la cachexie par le biais d'une balance énergétique négative chez les patients atteints de cancer